Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Some Swifties have been luckier than others when it comes to the surprise songs set of Taylor Swift’s The Eras Tour. Since the record-breaking tour kicked off in March 2023, Swift used the ...